SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002815
Filing Date
2021-11-03
Accepted
2021-11-03 16:04:19
Documents
85
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-20210930.htm   iXBRL 10-Q 4493411
2 EX-10.1 srpt-ex10_1.htm EX-10.1 44177
3 EX-31.1 srpt-ex31_1.htm EX-31.1 14194
4 EX-31.2 srpt-ex31_2.htm EX-31.2 14307
5 EX-32.1 srpt-ex32_1.htm EX-32.1 10077
6 EX-32.2 srpt-ex32_2.htm EX-32.2 9927
  Complete submission text file 0000950170-21-002815.txt   12862379

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srpt-20210930_cal.xml EX-101.CAL 72734
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20210930_lab.xml EX-101.LAB 455249
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srpt-20210930_def.xml EX-101.DEF 190263
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20210930.xsd EX-101.SCH 65020
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20210930_pre.xml EX-101.PRE 341069
12 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20210930_htm.xml XML 2549061
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 211375289
SIC: 2834 Pharmaceutical Preparations